CCO Independent Conference Coverage

CCO Independent Conference Coverage of the 2008 ICAAC/IDSA Annual Meeting*

October 25-28, 2008 | Washington, DC

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Timing and Choice of First-Line Antiretroviral Therapy

Track 1 of 6

Faculty:

Joel E. Gallant, MD, MPHW. David Hardy, MDKathleen E. Squires, MD
  • Joel E. Gallant, MD, MPH
  • W. David Hardy, MD
  • Kathleen E. Squires, MD

Management of Treatment-Experienced Patients

Track 2 of 6

Faculty:

Eric S. Daar, MDJoseph J. Eron, Jr., MDKimberly Y. Smith, MD, MPH
  • Eric S. Daar, MD
  • Joseph J. Eron, Jr., MD
  • Kimberly Y. Smith, MD, MPH

Clinical Complications of HIV and Its Therapy

Track 3 of 6

Faculty:

Judith S. Currier, MD, MScDonald P. Kotler, MDWilliam G. Powderly, MD
  • Judith S. Currier, MD, MSc
  • Donald P. Kotler, MD
  • William G. Powderly, MD

Hepatitis and Opportunistic Coinfections

Track 4 of 6

Faculty:

Richard E. Chaisson, MDSally Hodder, MDBruce Polsky, MD
  • Richard E. Chaisson, MD
  • Sally Hodder, MD
  • Bruce Polsky, MD

New Agents

Track 5 of 6

Overview of the 2008 ICAAC/IDSA Annual Meeting

Track 6 of 6

Expert Highlights



Antiretroviral Therapy in Treatment-Naive Patients

Anton L. Pozniak, MD, FRCP, reports on the 96-week results from the CASTLE, ARTEMIS, and HEAT clinical trials in treatment-naive patients as well as several analyses on the use of abacavir in patients with high HIV-1 RNA.


Audio File 7.85 MB

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.